Dave Weiner Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Dave Weiner

Stock Analyst at Piper Sandler

(4.6)
# 1448
Out of 5,477 analysts
8
Total ratings
Success rate
Average return
2 Stocks
Name Action PT Current % Upside Ratings Updated
MYGN Myriad Genetics
Maintains: Overweight
13 9
7.68 17.19% 3 May 15, 2025
LULU Lululemon Athletica
Upgrades: Buy
58 0
n/a n/a 5 Dec 14, 2017